| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,721 | 25,135 | 19,720 | 26,356 | | Cost of Revenue | 17,469 | 16,880 | 13,846 | 17,378 | | | Gross Profit | 10,252 | 8,255 | 5,874 | 8,978 | | | Operating Expenses | | Research Development | (86) | 66 | 20 | 25 | | Selling General and Administrative | 7,482 | 6,975 | 6,851 | 7,876 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 657 | 563 | 542 | 503 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,199 | 651 | (1,539) | 574 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 142 | 136 | 158 | 162 | | Earnings Before Interest And Taxes | 2,770 | 1,188 | (904) | 1,195 | | Interest Expense | 144 | 145 | 174 | 129 | | Income Before Tax | 2,626 | 1,043 | (1,078) | 1,066 | | Income Tax Expense | 423 | 26 | 24 | 139 | | Minority Interest | (914) | 34 | (34) |
-
| | | | Net Income From Continuing Ops | 2,203 | 1,051 | (1,136) | 927 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,289 | 1,051 | (1,136) | 929 | | Preferred Stock And Other Adjustments | 365 | (365) |
-
|
-
| | | Net Income Applicable To Common Shares | $1,654 | $686 | ($1,136) | $929 |
|
1.52% Nasdaq 0.00%
Income Statement
